Feprazone
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384611This classification denotes a cyclooxygenase inhibitor with the molecular formula C20H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BVX6J0CGR, chemically known as 3,5-pyrazolidinedione, 4-(3-methyl-2-butenyl)-1,2-diphenyl- but generally known as feprazone, which bears US NIH Compound Identifier 35455. European Medicines Agency schedules Feprazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07607MIG. The term FEPRAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules feprazone in its Anatomical Therapeutic Chemical (ATC) Classification. FEPRAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule feprazone under HS 29331990 and SITC 51571. As of Q4 2014, FEPRAZONE remains the US FDA Preferred Term for this commodity. Feprazone bears US NLM identifiers UMLS ID C0033056 and NCI Concept Code C65675. SMILES: O=C1N(N(C(=O)C1C/C=C(/C)C)C1CCCCC1)C1CCCCC1.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.